Free Trial

Cyclacel Pharmaceuticals (CYCC) SEC Filings & 10K Form

Cyclacel Pharmaceuticals logo
$0.30 -0.01 (-2.17%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$0.30 +0.01 (+2.36%)
As of 03/14/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cyclacel Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/14/2025
5:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
9:32 AM
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Doris Wong Sing Ee (Filed by)
Form SCHEDULE 13D
02/28/2025
3:46 PM
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lazar David E. (Filed by)
Form SCHEDULE 13D
02/28/2025
3:47 PM
Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
10:31 AM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Kiu Cu Seng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2025
10:31 AM
Chong Kwang Fock (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2025
10:32 AM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Doris Wong Sing Ee (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/24/2025
7:31 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:40 PM
ARMISTICE CAPITAL, LLC (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:45 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:46 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
3:40 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
5:02 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form DEF 14A
01/10/2025
3:46 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form PRER14A
01/10/2025
5:04 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:25 PM
Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:30 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form PRE 14A
01/07/2025
6:04 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
6:06 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
6:07 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:17 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
5:38 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/15/2024
5:05 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:21 PM
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/12/2024
4:10 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
4:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form RW
10/24/2024
3:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/30/2024
8:08 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/24/2024
8:34 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
8:56 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
05/14/2024
4:12 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:05 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
11:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form EFFECT
05/07/2024
8:53 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form DEFA14A
The real reason gold is soaring (and likely to continue) (Ad)

Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast!

Discover Garrett’s highly sought-after gold insights and seize this opportunity before it’s gone.
05/07/2024
8:56 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form ARS
05/07/2024
8:52 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form DEF 14A
05/06/2024
4:26 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/29/2024
4:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form RW
04/26/2024
4:20 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
4:23 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
7:20 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/21/2024
4:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CYCC) was last updated on 3/15/2025 by MarketBeat.com Staff
From Our Partners